Carregando...
Targeting ERα degradation by L-Tetrahydropalmatine provides a novel strategy for breast cancer treatment
The incidence and mortality of breast cancer (BCa) are the highest among female cancers. There are approximate 70% BCa that are classified as estrogen receptor alpha (ERα) positive. Therefore, targeting ERα is the most significantly therapeutic schedule. However, patients with breast cancer develop...
Na minha lista:
| Publicado no: | Int J Biol Sci |
|---|---|
| Principais autores: | , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Ivyspring International Publisher
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7294940/ https://ncbi.nlm.nih.gov/pubmed/32549765 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijbs.44005 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|